Postpartum Depression in the United States: A Systematic Review of Epidemiology, Risk Factors, and Contemporary

Motunrayo T Ojo-Rowland1, Okelue E Okobi2, Ikenna C Madubuike3,4

  • 1Department of Obstetrics and Gynaecology, Zaporozhye State Medical University, Zaporozhye, UKR.

Cureus
|July 1, 2026
PubMed

Postpartum depression (PPD) is a significant public health concern in the United States, affecting many women after childbirth and contributing to adverse maternal and infant outcomes. This study aimed to synthesize current evidence on the epidemiology, risk factors, and management of PPD, with particular attention to emerging therapeutic and digital care approaches. A systematic search of major databases identified 25 eligible studies published between 2010 and 2026. The findings indicate that PPD remains prevalent, with disparities strongly associated with race, socioeconomic status, and access to care. Risk factors are multifactorial and include prior mental illness, low social support, unintended pregnancy, and psychosocial stressors, with growing evidence also pointing to genetic contributions. Symptoms may emerge at different stages of the postpartum period, underscoring the importance of ongoing screening rather than a single assessment. While psychotherapy and antidepressant therapy remain the foundation of treatment, newer strategies such as telehealth, mobile health applications, and wearable technologies show promise in improving early detection and access to care. Overall, addressing PPD requires integrated, equitable, and patient-centered approaches to improve maternal and child health outcomes.

Related Concept Videos

Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Diagnostic and Statistical Manual of Mental Disorders (DSM)01:27

Diagnostic and Statistical Manual of Mental Disorders (DSM)

The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
Current Trends in Nursing II01:30

Current Trends in Nursing II

Trends in nursing are multifactorial and associated with changes in society, within the nursing profession, and in other professions. Notably, telehealth and remote nursing contribute to successful healthcare delivery for numerous patients and help reduce stress for nurses due to nursing shortages. Nurses can reach patients, monitor their conditions, and interact with them using computers, audio, visual accessories, and telephones—for example, remote patient monitoring systems. Likewise,...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...